Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Glucagon-like peptide-1, or GLP-1, is an incretin hormone your intestines naturally release after eating to regulate appetite and glucose metabolism. Recent clinical evidence shows that GLP-1 receptor agonists can reduce body weight by 15–22% when combined with lifestyle changes, making them a transformative option for weight management and type 2 diabetes control. PlexusDx specializes in precision GLP-1 therapy tailored to your genetic makeup and metabolic profile.
How GLP-1 Hormone Functions in Your Body
GLP-1 is produced by cells in your small intestine called L-cells when you consume food, particularly carbohydrates and proteins. Once released, this hormone travels through your bloodstream to your brain, where it activates receptors in the hypothalamus—the appetite control center—creating a sensation of fullness and satisfaction. At the same time, GLP-1 slows gastric emptying, meaning food moves more gradually from your stomach into your intestines, which extends the feeling of satiety and reduces overall calorie intake.
Beyond appetite suppression, GLP-1 also improves insulin secretion in response to blood glucose rises, helping your pancreas respond more effectively to meals. This dual action—reducing hunger while enhancing blood sugar regulation—explains why GLP-1 receptor agonists have become central to modern metabolic medicine. The hormone works naturally within your body's existing physiology rather than forcing artificial restrictions on eating patterns.
GLP-1 and Weight Loss: Clinical Evidence
Clinical trials demonstrate that GLP-1 receptor agonist therapy produces sustained weight loss in individuals with overweight and obesity. Landmark studies show participants achieving an average weight reduction of 15–22% of baseline body weight over 68 weeks, with some patients maintaining these losses for over two years with continued treatment. The mechanism combines reduced calorie intake—from diminished appetite and slower stomach emptying—with improved metabolic efficiency and modest increases in energy expenditure.
PlexusDx's compounded semaglutide injection delivers GLP-1 receptor activation through a licensed 503A pharmacy formula. Starting at $149 monthly, the treatment allows your dose to increase gradually as your body adapts, with your monthly price remaining flat regardless of dose adjustments. This approach removes the barrier of escalating costs while your provider optimizes your therapy for maximum effectiveness.
GLP-1's Role in Type 2 Diabetes Management
For individuals with type 2 diabetes, GLP-1 receptor agonists offer a distinct advantage: they lower hemoglobin A1C levels by an average of 1.0–1.5 percentage points while reducing cardiovascular risk and promoting weight loss simultaneously. Unlike some diabetes medications that carry the risk of weight gain or hypoglycemia, GLP-1 agents tend to be weight-neutral or weight-favorable, addressing two major health concerns at once. The hormone's ability to stimulate insulin release only when blood glucose is elevated makes it safer than older classes of diabetes drugs.
Patients using GLP-1 therapy frequently experience improved energy levels and reduced blood sugar variability throughout the day. Many report better sleep quality and more stable mood once their glucose metabolism normalizes. This metabolic stabilization often extends beyond glucose control—patients often notice reduced cravings for processed foods and improved appetite awareness.
Personalized GLP-1 Therapy with Genetic Testing
Not all individuals respond identically to GLP-1 therapy because genetic variations affect how your body processes these medications and regulates appetite-related pathways. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes key genetic markers including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—variants that influence your GLP-1 receptor sensitivity and metabolic response. By mapping 14 distinct peptide pathways and 150+ genetic insights, PlexusDx identifies which GLP-1 formulation and dosing strategy will be most effective for your unique biology.
This precision approach means PlexusDx can recommend whether compounded semaglutide injection, oral semaglutide, tirzepatide, or a dual-compound GLP-Squared formula is right for you before you commit to a long-term regimen. Your genetic profile reveals your body's natural appetite-suppression pathways and glucose-handling capacity, allowing your provider to predict your likely response and adjust your treatment plan proactively. All PlexusDx medications come from licensed 503A compounding pharmacies and are available in all 50 states without insurance or membership fees.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between GLP-1 and insulin?
GLP-1 is a hormone that improves your body's natural insulin production and reduces appetite, while insulin directly lowers blood sugar by allowing cells to absorb glucose. GLP-1 therapy works with your body's existing systems, whereas insulin replaces or supplements your pancreas's output. Many people with type 2 diabetes achieve excellent results with GLP-1 alone, without needing insulin.
How quickly does GLP-1 therapy produce weight loss?
Most patients notice appetite reduction within 1–2 weeks of starting treatment, though meaningful weight loss typically becomes measurable after 4–8 weeks as your body adjusts to lower calorie intake. Clinical trials show progressive weight loss over 16–68 weeks, with optimal results appearing at 6–12 months of consistent therapy. PlexusDx patients often report sustained loss when combined with balanced nutrition and regular activity.
Does PlexusDx require insurance or membership to access GLP-1 therapy?
No. PlexusDx serves all 50 states without insurance requirements or membership fees. Compounded semaglutide injection starts at $149/month, and your dose can increase without your price changing. Medications are HSA/FSA eligible, and all formulations come from licensed 503A compounding pharmacies.
What are the common side effects of GLP-1 therapy?
The most frequent side effects are mild gastrointestinal effects—nausea, constipation, or reduced appetite for foods you normally enjoy—which typically resolve within 2–4 weeks as your body adapts. Serious adverse events are rare when prescribed appropriately. Your PlexusDx provider monitors your response and adjusts dosing to minimize discomfort while maximizing therapeutic benefit.
How does the Precision Peptide Genetic Test help with GLP-1 treatment?
PlexusDx's Precision Peptide Genetic Test identifies your genetic variants in GLP-1 receptor pathways and metabolic genes, predicting how sensitive you'll be to GLP-1 therapy and which formulation—semaglutide, tirzepatide, or dual-compound GLP-Squared—will work best for you. This $99 add-on test maps 150+ genetic insights across 14 peptide pathways, allowing your provider to personalize your therapy before starting treatment for faster, more sustainable results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Semaglutide Dosing: Does a Higher Dose Work Better for Weight Loss?
A Comprehensive Look at How Long Does 1 Pen of Ozempic Last for Your Health Journey